3//SEC Filing
Edwards Lifesciences Holding, Inc. 3
Accession 0000899243-19-004452
CIK 0000764579other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:13 PM ET
Size
13.8 KB
Accession
0000899243-19-004452
Insider Transaction Report
Form 3
Edwards Lifesciences Holding, Inc.
10% Owner
Holdings
- 0(indirect: See Footnotes)
Common Stock, $0.004 par value
- 0(indirect: See Footnotes)
Convertible Preferred Stock, $0.001 par value
- 0(indirect: See Footnotes)
Exchangeable Preferred Stock, $0.001 par value
- (indirect: See Footnotes)
Stock Option (right to buy)
→ Common Stock, $0.004 par value per share (0 underlying)
Edwards Lifesciences Corp
10% Owner
Holdings
- 0(indirect: See Footnotes)
Common Stock, $0.004 par value
- 0(indirect: See Footnotes)
Convertible Preferred Stock, $0.001 par value
- 0(indirect: See Footnotes)
Exchangeable Preferred Stock, $0.001 par value
- (indirect: See Footnotes)
Stock Option (right to buy)
→ Common Stock, $0.004 par value per share (0 underlying)
Footnotes (6)
- [F1]On February 11, 2019, CAS Medical Systems, Inc. ("Issuer"), Edwards Lifesciences Holding, Inc., a Delaware corporation and a wholly-owned subsidiary of Edwards Lifesciences Corporation ("Acquiror") and Crown Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Acquiror ("Merger Sub"), entered into an Agreement and Plan of Merger (the "Merger Agreement") pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Merger Sub will merge with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving company and a wholly-owned subsidiary of Acquiror.
- [F2]Edwards Lifesciences Corporation ("Edwards") and Acquiror may be deemed to have beneficial ownership of (i) 3,706,406 shares of Common Stock, $0.004 par value, of Issuer ("Common Stock") held by Thomas, McNerney & Partners, L.P., TMP Nominee II, L.L.C., TMP Associates II, L.P., Thomas M. Patton, Jeffery A. Baird, John K. Gamelin, Paul B. Benni, Alan W. Milinazzo, Paul A. Molloy, Gregory P. Rainey, James E. Thomas, Kathleen A. Tune and Kenneth R. Weisshaar (each, a "Stockholder"); (ii) 150,000 shares of Exchangeable Preferred Stock, $0.001 par value, and Convertible Preferred Stock, $0.001 par value, of Issuer (collectively, "Preferred Stock") held by Thomas, McNerney & Partners, L.P., TMP Nominee II, L.L.C., and TMP Associates II, L.P.; and
- [F3](Continued from Footnote 2) (iii) 1,840,000 shares of Common Stock issuable in the aggregate upon the vesting and exercise of options to purchase Common Stock granted to Thomas M. Patton, Jeffery A. Baird, John K. Gamelin, Paul B. Benni, Alan W. Milinazzo, Paul A. Molloy, Gregory P. Rainey, James E. Thomas, Kathleen A. Tune and Kenneth R. Weisshaar, as a result of entering into voting agreements (together, the "Voting Agreements"), dated as of February 11, 2019, with each Stockholder. A copy of the form of Voting Agreement that Acquiror entered into with each Stockholder was filed as an exhibit to Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2019. Pursuant to the Voting Agreements, the Stockholders agreed, among other things and subject to the terms and conditions therein, to vote their shares in favor of the adoption of the Merger Agreement and the transactions contemplated thereby, including the Merger,
- [F4](Continued from Footnote 3) and against any alternative proposal. In addition, each Stockholder waived appraisal rights and provided an irrevocable proxy to Acquiror to vote in favor of the Merger, including by voting for the adoption of the Merger Agreement. The Voting Agreements do not limit or restrict the Stockholders solely in their capacity as a director or officer of Issuer from acting in such capacity. Each Voting Agreement terminates upon the earliest to occur of (i) mutual consent by the relevant Stockholder and Acquiror; (ii) the termination of the Merger Agreement in accordance with its terms; (iii) the effective time of the Merger; and (iv) Issuer's board of directors changing its recommendation that its stockholders adopt the Merger Agreement in accordance with the terms of the Merger Agreement.
- [F5](Continued from Footnote 4) Neither the filing of this Form 3 nor any of its contents shall be deemed to constitute an admission by Edwards or Acquiror that it is the beneficial owner of any of the shares and any such beneficial ownership is expressly denied.
- [F6]Neither Edwards nor Acquiror has any pecuniary interest in any of the shares.
Documents
Issuer
CAS MEDICAL SYSTEMS INC
CIK 0000764579
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001767918
Filing Metadata
- Form type
- 3
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 7:13 PM ET
- Size
- 13.8 KB